<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-135305" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>CNS Tuberculosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Monica</given-names>
          </name>
          <aff>Government Medical College Hospital, Sector 32-B, Chandigarh, India, 160030</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tobin</surname>
            <given-names>Ellis H.</given-names>
          </name>
          <aff>College of Nanoscale Science and Engineering State University of New York</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Munakomi</surname>
            <given-names>Sunil</given-names>
          </name>
          <aff>Kathmandu University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Monica Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ellis Tobin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sunil Munakomi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-135305.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tuberculosis is prevalent worldwide. One catastrophic manifestation of extrapulmonary tuberculosis is central nervous system (CNS) involvement,&#x000a0;which can present as&#x000a0;either tubercular meningitis (TBM), CNS tuberculoma, or spinal arachnoiditis. CNS tuberculosis (CNS-TB) may develop&#x000a0;from hematogenous spread or the rupture of subependymal or meningeal tubercular foci.&#x000a0;The condition carries the highest morbidity and mortality among all&#x000a0;tuberculosis forms.</p>
        <p>Diagnosing CNS-TB poses challenges due to its paucibacillary nature and the limitations of conventional diagnostic methods. Clinical scoring systems exist but have flaws, emphasizing the need for a comprehensive approach, including history, examination, cerebrospinal fluid (CSF) analysis, and imaging. Though confirmatory evidence from CSF is difficult to obtain, molecular techniques like polymerase chain reaction offer valuable assistance.</p>
        <p>Epidemiological factors and extraneural infections can&#x000a0;help identify patients with&#x000a0;CNS-TB. CSF examination, including microscopy and culture, remains crucial. However, newer techniques like Xpert <italic toggle="yes">Mycobacterium tuberculosis</italic>/rifampin, loop-mediated isothermal amplification assay, and metagenomic sequencing show promise. Imaging, particularly magnetic resonance, is pivotal in&#x000a0;detecting characteristic findings, such as basilar leptomeningeal enhancement and tuberculomas, aiding in timely and accurate diagnosis.</p>
        <p>This activity for healthcare professionals is designed to improve learners' competence in evaluating and treating CNS-TB. Participants gain a deeper understanding of the condition's pathophysiology, nuanced presentations, diagnostic approaches, and therapeutic strategies. Learners become prepared to collaborate effectively within an interprofessional team&#x000a0;to enhance outcomes for patients with CNS-TB.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the&#x000a0;signs and symptoms indicative of central nervous system tuberculosis.</p></list-item><list-item><p>Create a clinically guided diagnostic plan for an individual with suspected central nervous system tuberculosis.</p></list-item><list-item><p>Implement a personalized management strategy for a patient diagnosed with&#x000a0;central nervous system tuberculosis.</p></list-item><list-item><p>Collaborate with the interprofessional team to educate, treat, and monitor patients with&#x000a0;central nervous system tuberculosis&#x000a0;to improve&#x000a0;health outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135305&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135305">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-135305.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mycobacterium tuberculosis is responsible for 5.9% of community-acquired central nervous system (CNS) infections worldwide.<xref ref-type="bibr" rid="article-135305.r1">[1]</xref>&#x000a0;Neurological or&#x000a0;CNS tuberculosis (CNS-TB) may take 1 of 3 clinicopathological forms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tubercular meningitis (TBM),&#x000a0;affecting&#x000a0;the CNS&#x000a0;diffusely</p>
          </list-item>
          <list-item>
            <p>CNS tuberculoma, the focal type</p>
          </list-item>
          <list-item>
            <p>Spinal arachnoiditis, also&#x000a0;called&#x000a0;"tuberculous&#x000a0;radiculomyelitis" (TBRM),&#x000a0;involving&#x000a0;only the spine&#x000a0;<xref ref-type="bibr" rid="article-135305.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>Of these forms, TBM predominates as it causes&#x000a0;70% to 80% of&#x000a0;CNS-TB&#x000a0;infections.&#x000a0;TBM&#x000a0;presents&#x000a0;with&#x000a0;subacute-to-chronic meningitis signs and symptoms, with disease severity commensurate with illness duration.<xref ref-type="bibr" rid="article-135305.r3">[3]</xref>&#x000a0;Diagnosis is fraught with challenges and is often delayed due to the varied and nonspecific presentations.<xref ref-type="bibr" rid="article-135305.r4">[4]</xref>&#x000a0;Besides the clinical clues, diagnostic indicators in cerebrospinal fluid (CSF) include mononuclear pleocytosis, low sugar values, and high protein concentrations. Identifying&#x000a0;<italic toggle="yes">Mycobacterium tuberculosis</italic>&#x000a0;(MTB) in CSF by staining, culture methods, and molecular analysis is confirmatory but may be challenging.<xref ref-type="bibr" rid="article-135305.r5">[5]</xref>&#x000a0;</p>
        <p>Advanced radiological imaging techniques are usually of great assistance in making presumptive diagnoses. Vasculitic infarcts, cranial nerve (CN) palsies, multiple neurological deficits, and hydrocephalus frequently complicate CNS-TB. A strong clinical suspicion is typically enough to start prompt antitubercular therapy.&#x000a0;The&#x000a0;4-drug regimen of isoniazid, rifampin, pyrazinamide, and ethambutol with adjunctive corticosteroid reduces morbidity and mortality.&#x000a0;However,&#x000a0;CNS-TB diagnosis and management may be complicated by drug resistance, immune reconstitution inflammatory syndrome (IRIS), and HIV coinfection.</p>
        <p>Treatment efficacy depends upon the timing. Multiple factors determine the prognosis, the most important being the TBM clinical stage at&#x000a0;initial&#x000a0;presentation. Untreated or unrecognized TBM may cause death within 5&#x000a0;to 8 weeks of&#x000a0;disease&#x000a0;onset.</p>
        <p>
<bold>Normal Protective Barriers of the Central Nervous System</bold>
</p>
        <p>The CNS is shielded from potentially harmful blood-borne bacteria by&#x000a0;2&#x000a0;vascular barriers: the blood-brain barrier (BBB) and blood-CSF barrier (BCSFB). The BBB, primarily consisting of brain microvascular endothelial cells, regulates the passage of substances between the blood and CNS with tight junctions and specialized transport mechanisms. Supporting elements like pericytes and astrocytes also play crucial roles in maintaining BBB integrity. In contrast, the BCSFB is formed by choroid plexus epithelial cells and the arachnoid membrane, similarly employing tight junctions to control the exchange between blood and CSF.</p>
        <p>However,&#x000a0;<italic toggle="yes">in vitro</italic>&#x000a0;and animal models&#x000a0;have shown that&#x000a0;MTB can invade brain endothelial cells by rearranging cellular actin molecules. The MTB gene&#x000a0;<italic toggle="yes">Rv0931c</italic>&#x000a0;is implicated in promoting CNS infection by facilitating bacillary endothelial adhesion. MTB may also exploit the&#x000a0;"Trojan horse" mechanism, utilizing infected macrophages and neutrophils to traverse the BBB.<xref ref-type="bibr" rid="article-135305.r6">[6]</xref></p>
      </sec>
      <sec id="article-135305.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>MTB is the organism responsible for CNS-TB. This alcohol and acid-fast bacillus&#x000a0;may be visualized microscopically&#x000a0;using the Ziehl-Neelsen, auramine-rhodamine, and Kinyoun stains. The etiological contribution of the other&#x000a0;4&#x000a0;<italic toggle="yes">Mycobacterium</italic> species in causing CNS-TB has not been established. Humans are the only known MTB hosts&#x000a0;or reservoirs. Infection is primarily acquired through airborne aerosols from infected individuals.</p>
      </sec>
      <sec id="article-135305.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Around&#x000a0;25% to 30% of the human population is infected with MTB. CNS-TB is reported in 1% to 2% of individuals with active tuberculosis.<xref ref-type="bibr" rid="article-135305.r7">[7]</xref>&#x000a0;CNS-TB accounts for 5% to 8% of extrapulmonary tuberculosis (EPTB) cases in immunocompetent hosts. Approximately 70% to 80% of CNS-TB cases present as TBM.<xref ref-type="bibr" rid="article-135305.r8">[8]</xref>&#x000a0;</p>
        <p>Tuberculomas are seen mostly in India and parts of Asia and may account for 20% to 30% of all intracranial space-occupying lesions.<xref ref-type="bibr" rid="article-135305.r9">[9]</xref>&#x000a0;An estimated 9,272 CNS-TB cases were diagnosed in the U.S. in 2016.<xref ref-type="bibr" rid="article-135305.r10">[10]</xref>&#x000a0;Since 2010,&#x000a0;the incidence of tuberculosis has fallen by 2% to 3% every year, especially in 2020, probably due to the pandemic mitigation efforts, travel restrictions, or delayed or missed tuberculosis diagnoses.<xref ref-type="bibr" rid="article-135305.r11">[11]</xref>&#x000a0;However, the incidence of reported&#x000a0;tuberculosis rose&#x000a0;by 9.4% between 2020 and 2021.<xref ref-type="bibr" rid="article-135305.r12">[12]</xref>&#x000a0;Despite the diagnostic and treatment advances, CNS&#x02013;TB still carries&#x000a0;a mortality rate of 15% to 40%, especially in children.<xref ref-type="bibr" rid="article-135305.r13">[13]</xref></p>
      </sec>
      <sec id="article-135305.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The 3 CNS-TB forms develop by different mechanisms. Understanding&#x000a0;each condition's pathophysiology, explained below, is key to diagnosis.</p>
        <p>
<bold>Tuberculous Meningitis</bold>
</p>
        <p>CNS-TB may arise from&#x000a0;hematogenous MTB dissemination following a primary lung infection (pulmonary tuberculosis or PTB) or late disease reactivation.<xref ref-type="bibr" rid="article-135305.r14">[14]</xref>&#x000a0;Meningeal or ependymal seeding results from this spread,&#x000a0;forming&#x000a0;multiple small granulomatous foci or tubercles (Rich foci) that may proliferate, coalesce, caseate, and rupture into the subarachnoid space before the onset of meningitis.&#x000a0;Free&#x000a0;bacilli produce an intense, cytokine-mediated host inflammatory response, leading to the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Leptomeningitis, ependymitis, choroid plexitis, encephalitis, and pachymeningitis with basal and opticochiasmatic arachnoiditis (OCA)</p>
          </list-item>
          <list-item>
            <p>Vasculitis with endarteritis and infarcts</p>
          </list-item>
          <list-item>
            <p>Hydrocephalus secondary to disturbed CSF flow and absorption</p>
          </list-item>
        </list>
        <p>The extensive exudative arachnoiditis at the brain's base and the optic chiasma&#x000a0;entraps multiple CNs in the area,&#x000a0;including the abducens, optic, oculomotor, and trochlear. Arteritis and phlebitis result in vasculitic infarcts due to arterial vasospasm, thrombosis, or hemorrhage.<xref ref-type="bibr" rid="article-135305.r15">[15]</xref>&#x000a0;The disparate inflammatory response in individuals with TBM is thought to be due to&#x000a0;human genetic polymorphisms in the leukotriene A4 hydrolase gene and toll-interleukin-1 receptor domain.<xref ref-type="bibr" rid="article-135305.r16">[16]</xref>&#x000a0;</p>
        <p>Inflammation can spread to the basal cisterns&#x000a0;in many patients symptomatic for&#x000a0;at least&#x000a0;3&#x000a0;weeks, disrupting CSF circulation and absorption and producing communicating hydrocephalus<xref ref-type="bibr" rid="article-135305.r17">[17]</xref>&#x000a0;Obstructive&#x000a0;hydrocephalus occurs, though rarely, due to ependymitis-induced narrowing of the cerebral aqueduct or compression by brainstem tuberculoma in the 4th ventricle.</p>
        <p>
<bold>Tuberculoma</bold>
</p>
        <p>Deep-seated tubercular granulomatous foci acquired during initial bacteremia may coalesce and develop into conglomerated caseous masses called "tuberculomas" without producing meningitis. Often, tuberculomas may be present as clinically silent single or multiple lesions in patients with TBM and detected on brain imaging.&#x000a0;Tuberculomas may form tubercular abscesses in immunosuppressed individuals. Spinal cord tuberculoma may&#x000a0;form&#x000a0;at any cord level&#x000a0;through&#x000a0;similar&#x000a0;mechanisms&#x000a0;or by local extension from&#x000a0;nearby&#x000a0;tubercular spondylitis.</p>
        <p>
<bold>Spinal Arachnoiditis</bold>
</p>
        <p>Spinal arachnoiditis may arise as a result of previous TBM or vertebral osteomyelitis. The caseating inflammation may progress over weeks to months, leading to nerve root clumping or cord encasement (partial/total) by the thick gelatinous exudate or fibrous mass.</p>
      </sec>
      <sec id="article-135305.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, the thick inflammatory meningeal exudate is granulomatous, with epithelioid macrophages, Langhans' giant cells, lymphocytes, plasma cells, and fibroblasts (see <bold>Image</bold>. Tuberculous&#x000a0;Meningitis Histopathology). Tuberculomas are bigger encapsulated epithelioid granulomas with similar pleocytosis arranged in layers but a necrotic caseous center&#x000a0;without&#x000a0;pus. A tuberculous abscess has a thick wall with a liquefied pus core containing viable MTB bacilli.</p>
      </sec>
      <sec id="article-135305.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The different CNS-TB forms produce various manifestations. The historical and physical features of each type are explained below.</p>
        <p>
<bold>Tuberculous Meningitis</bold>
</p>
        <p>Patients with TBM often&#x000a0;present with a&#x000a0;subacute, progressive febrile illness beginning with a prodrome of constitutional&#x000a0;symptoms, including lassitude, malaise, night sweats, and intermittent headaches.&#x000a0;A well-defined meningitic phase is observed in the following fortnight or more. This phase includes protracted headaches, vomiting, personality changes, confusion, and meningismus symptoms. Patients with TBM may deteriorate rapidly, developing varying degrees of confusion and coma. Seizures, multiple CN deficits, focal neurological impairments, and stroke syndromes may supervene.</p>
        <p>Children may have prominent irritability, vomiting, and focal or generalized convulsions. Individuals with untreated TBM may not survive beyond 5&#x000a0;to 8 weeks of illness. CN palsies are seen in 20% to 30% of patients with TBM, mostly involving CN VI.<xref ref-type="bibr" rid="article-135305.r18">[18]</xref>&#x000a0;OCA with blindness is a significant TBM complication.<xref ref-type="bibr" rid="article-135305.r19">[19]</xref></p>
        <p>
<bold>Tuberculoma</bold>
</p>
        <p>This CNS-TB manifestation should be included in the differential diagnosis of space-occupying lesions in young individuals. The usual&#x000a0;symptoms include headaches, seizures, progressive neurological deficits, and papilledema with or without meningitis.</p>
        <p>
<bold>Spinal Arachnoiditis</bold>
</p>
        <p>Individuals with this condition&#x000a0;present with radiculomyelopathy secondary to nerve root entrapment and cord encasement due to severe arachnoiditis at single or multiple levels. Patients may complain of radicular pain, hyperesthesia, flaccid paralysis, and urinary or stool incontinence. Cord infarction may occur due to&#x000a0;anterior spinal&#x000a0;arteritis and thrombosis (see <bold>Image.</bold> Pott Spine).</p>
        <p>
<bold>Atypical Presentations</bold>
</p>
        <p>CNS-TB&#x000a0;may manifest&#x000a0;in 10% to 30% of adult patients with&#x000a0;miliary tuberculosis. The condition arises from hematogenous MTB dissemination, with immunocompromised patients being the most vulnerable.&#x000a0;The&#x000a0;brain parenchyma may show multiple scattered tiny granulomatous foci, which may or may not show ring enhancement.<xref ref-type="bibr" rid="article-135305.r20">[20]</xref>&#x000a0;</p>
        <p>TBM may also manifest as progressive cognitive dysfunction or psychosis in rare cases.&#x000a0;The condition may&#x000a0;likewise mimic acute encephalitis or typical pyogenic meningitis.&#x000a0;Atypical cases&#x000a0;may present with florid cranial polyneuropathy or hydrocephalus complications that precede meningitis signs.<xref ref-type="bibr" rid="article-135305.r21">[21]</xref>&#x000a0;</p>
        <p>
<bold><bold>Tuberculous Meningitis</bold> and HIV Infection</bold>
</p>
        <p>HIV coinfection does not affect CNS-TB's clinical manifestations, CSF picture, or prognosis. However, HIV-seropositive TBM may have a normal CSF,&#x000a0;with&#x000a0;radiographic clues holding greater importance in such cases.&#x000a0;Cryptococcal meningitis is a close differential diagnosis and may sometimes occur concurrently. Intracerebral tuberculomas are more likely to occur in HIV patients than in the general population, often as multiloculated tubercular abscesses. CNS lymphoma or toxoplasma encephalitis closely mimics the condition.&#x000a0;However,&#x000a0;cisternal enhancement, basal ganglia infarction, and communicating hydrocephalus favor&#x000a0;a&#x000a0;CNS-TB diagnosis.<xref ref-type="bibr" rid="article-135305.r22">[22]</xref></p>
      </sec>
      <sec id="article-135305.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Clinical Diagnosis of Tuberculous Meningitis</bold>
</p>
        <p>CNS-TB is a paucibacillary disease, often eluding definitive diagnosis.<xref ref-type="bibr" rid="article-135305.r23">[23]</xref>&#x000a0;Conventional diagnostic techniques are insensitive and laborious.<xref ref-type="bibr" rid="article-135305.r24">[24]</xref>&#x000a0;Clinical scoring algorithms for definitive CNS-TB diagnosis are flawed and unreliable.<xref ref-type="bibr" rid="article-135305.r25">[25]</xref><xref ref-type="bibr" rid="article-135305.r26">[26]</xref>&#x000a0;With early and precise identification&#x000a0;being crucial for survival, diagnosis typically relies on a combination of evidence from patient history, neurological examination, CSF analysis, and radiological imaging.<xref ref-type="bibr" rid="article-135305.r27">[27]</xref>&#x000a0;</p>
        <p>Newer molecular techniques help confirm&#x000a0;the presence of MTB in CSF, which is often&#x000a0;challenging.&#x000a0;Still, a definitive diagnosis&#x000a0;is not always achievable, necessitating presumptive and prompt treatment initiation to mitigate delay-related risks. Investigating epidemiological factors and personal risk variables is crucial, even though such data may be limited in adults. Notably, active&#x000a0;tuberculosis exposure can be identified in 70% to 90% of&#x000a0;children with TBM.</p>
        <p>Identifying active extraneural infection&#x000a0;occasionally&#x000a0;aids in determining a presumptive diagnosis. Chest radiographs&#x000a0;are beneficial in&#x000a0;most pediatric TBM cases and approximately 50% of adult cases (see&#x000a0;<bold>Image</bold>. Pulmonary Tuberculosis). Laboratory analysis may indicate mild anemia, lymphocytosis, and hyponatremia. A positive tuberculin test offers supportive evidence, notably in children, though a negative result does not rule out the diagnosis.&#x000a0;Funduscopy&#x000a0;may also uncover papilledema and choroid tubercles, aiding diagnosis (see&#x000a0;<bold>Image</bold>.&#x000a0;Tuberculoma on Funduscopy).<xref ref-type="bibr" rid="article-135305.r28">[28]</xref></p>
        <p>
<bold>Cerebrospinal Fluid Examination and Culture</bold>
</p>
        <p>A pellicle or cobweb may form during gross CSF examination, which is representative but not pathognomonic of TBM. A xanthochromic CSF indicates&#x000a0;unusually high protein content. CSF cytological analysis typically shows the total cell count between 100 and 500/mm3 in the majority.&#x000a0;Less than 100 cells/mm3 are present in 15% of cases. Pleocytosis may be absent in people of advanced age or with miliary tuberculosis-related&#x000a0;CNS-TB&#x000a0;or HIV coinfection.</p>
        <p>The CSF cell number may be 500&#x000a0;to 1,500 cells/mm3 in 20% of cases. A transient polymorphonuclear predominance or mixed pleocytosis may also be observed&#x000a0;in the first week of illness. However,&#x000a0;predominant lymphomononuclear pleocytosis is the typical CSF&#x000a0;finding in TBM. CSF protein concentration varies from 100&#x000a0;to 500 mg/dl. About 25% of cases may have less than 100 mg/dl of protein, and 10% may have greater than 500 mg/dl. Values exceeding&#x000a0;1&#x000a0;g/dl&#x000a0;is&#x000a0;characteristic of severe adhesive spinal arachnoiditis and portends a poor prognosis. The CSF glucose level is less than 45 mg/dl in 80% of cases.&#x000a0;However, unlike acute pyogenic meningitis, CSF glucose is never undetectable.</p>
        <p>
<bold>Microbiological Tests</bold>
</p>
        <p>Demonstrating MTB in the CSF smear using Ziehl-Neelsen and auramine-rhodamine staining is crucial but elusive. The detection rates range from 12.5% to 69%, showing significant variability across reports. Traditional Lowenstein-Jensen culture takes&#x000a0;4 to 8 weeks for growth reporting but detects MTB only in 25% to 70% of cases. Liquid culture media like Septi-Chek/Middlebrook 7H9 enhance detection rates.&#x000a0;Detection often&#x000a0;improves&#x000a0;with larger sample volumes, more CSF&#x000a0;specimens, centrifugation, and preparing thick smears from the pellicle.<xref ref-type="bibr" rid="article-135305.r29">[29]</xref></p>
        <p>
<bold>Molecular Diagnostic Techniques</bold>
</p>
        <p>The World Health Organization recommends Xpert MTB/rifampin (Xpert MTB/RIF), a polymerase chain reaction technique,&#x000a0;to be used for molecular TBM diagnosis in CSF specimens, particularly in situations with limited sample volume.<xref ref-type="bibr" rid="article-135305.r30">[30]</xref><xref ref-type="bibr" rid="article-135305.r31">[31]</xref>&#x000a0;This quick and automated cartridge-based nucleic acid amplification test targets&#x000a0;MTB's&#x000a0;<italic toggle="yes">rpob</italic>&#x000a0;gene, enabling simultaneous detection of MTB and rifampin resistance.<xref ref-type="bibr" rid="article-135305.r32">[32]</xref>&#x000a0;An Xpert MTB/RIF meta-analysis demonstrated a sensitivity of 80.5% and a specificity of 97.8%.<xref ref-type="bibr" rid="article-135305.r33">[33]</xref>&#x000a0;Loop-mediated isothermal amplification assay is another promising, rapid, and cost-effective technique in resource-limited regions.<xref ref-type="bibr" rid="article-135305.r34">[34]</xref></p>
        <p>CSF assays for the&#x000a0;MTB cell wall glycolipid lipoarabinomannan show sensitivity comparable to Xpert MTB/RIF, potentially aiding TBM diagnosis in patients with HIV, particularly in resource-limited settings.<xref ref-type="bibr" rid="article-135305.r35">[35]</xref>&#x000a0;Lipoarabinomannan detection in CSF demonstrates high TBM specificity.<xref ref-type="bibr" rid="article-135305.r36">[36]</xref>&#x000a0;CSF interferon-&#x003b3; release assays have superior diagnostic accuracy&#x000a0;over&#x000a0;blood&#x000a0;interferon-&#x003b3; release assays&#x000a0;in evaluating TBM.<xref ref-type="bibr" rid="article-135305.r37">[37]</xref><xref ref-type="bibr" rid="article-135305.r38">[38]</xref></p>
        <p>Metagenomic next-generation sequencing (mNGS) has recently been shown to provide rapid and sensitive diagnostic capability in TBM.<xref ref-type="bibr" rid="article-135305.r39">[39]</xref><xref ref-type="bibr" rid="article-135305.r40">[40]</xref>&#x000a0;Adding mNGS to CSF analysis may&#x000a0;prove to&#x000a0;be a valuable diagnostic tool&#x000a0;when combined with traditional diagnostic methods.</p>
        <p>
<bold>Adenosine Deaminase</bold>
</p>
        <p>Adenosine deaminase (ADA) is an enzyme produced by T-lymphocytes&#x000a0;that&#x000a0;serves as an indirect measure of&#x000a0;the host response to MTB and&#x000a0;holds significant diagnostic value.&#x000a0;Elevated ADA levels are observed in the CSF of 60% to 100% of individuals with TBM, with a cutoff value of 9.5 U/L used to distinguish TBM from non-TBM cases. Dynamic CSF-ADA activity monitoring may provide further diagnostic assistance.<xref ref-type="bibr" rid="article-135305.r41">[41]</xref>&#x000a0;One study&#x000a0;demonstrates that ADA measurement has a sensitivity of 92.5% and a specificity of 97%, with the cutoff set&#x000a0;to&#x000a0;10 U/L.<xref ref-type="bibr" rid="article-135305.r42">[42]</xref></p>
        <p>
<bold>Imaging&#x000a0;</bold>
</p>
        <p>Neuroimaging is vital in diagnosing&#x000a0;suspected CNS-TB&#x000a0;cases,&#x000a0;helping ensure a timely and correct diagnosis. Neuroimaging ideally must include the entire neuroaxis. The evaluation modalities include brain computed tomography (CT) or magnetic resonance imaging, with contrast-enhanced MRI having a superior delineating ability.&#x000a0;Newer techniques further enhance&#x000a0;MRI's&#x000a0;diagnostic&#x000a0;reliability&#x000a0;in atypical or difficult cases (see&#x000a0;<bold>Image</bold>. Tuberculous&#x000a0;Meningitis on Magnetic Resonance Imaging).<xref ref-type="bibr" rid="article-135305.r43">[43]</xref></p>
        <p>The diagnostic triad of TBM consists of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Extensive basilar leptomeningeal enhancement and&#x000a0;exudates,&#x000a0;found&#x000a0;in 38% to 89%</p>
          </list-item>
          <list-item>
            <p>Hydrocephalus, detected in 60% to 75%</p>
          </list-item>
          <list-item>
            <p>Cerebral&#x000a0;infarcts,&#x000a0;seen&#x000a0;in 15% to 28%, followed by tuberculoma in another 27% of cases&#x000a0;<xref ref-type="bibr" rid="article-135305.r44">[44]</xref><xref ref-type="bibr" rid="article-135305.r45">[45]</xref><xref ref-type="bibr" rid="article-135305.r46">[46]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>TBM&#x000a0;exudates have certain areas of predilection. Optochiasmatic arachnoiditis is almost pathognomonic&#x000a0;of TBM.<xref ref-type="bibr" rid="article-135305.r47">[47]</xref>&#x000a0;The other areas include the interpeduncular fossa,&#x000a0;perimesencephalic&#x000a0;region, cisterna&#x000a0;ambiens, and suprasellar and Sylvian cisterns. Exudates are best discerned on MRI&#x000a0;fluid-attenuated inversion recovery&#x000a0;sequences, while enhanced meninges are&#x000a0;more visible on postcontrast spin echo MRI (see Image. Tuberculous Meningitis on MRI).</p>
        <p>On CT, intense basal cisternal enhancement may appear as a characteristic spider leg appearance&#x000a0;(see&#x000a0;<bold>Image</bold>.&#x000a0;Tuberculous&#x000a0;Meningitis on Computed Tomography).<xref ref-type="bibr" rid="article-135305.r48">[48]</xref>&#x000a0;Imaging features are specific (95&#x02013;100%) for TBM only when&#x000a0;interpreted&#x000a0;in combination.&#x000a0;However,&#x000a0;these findings&#x000a0;have reduced&#x000a0;sensitivity if taken individually.</p>
        <p>TBM's&#x000a0;basal pachymeningitis involves mostly the middle cerebral artery's M1 segment, circle of Willis, and lenticulostriate and thalamus-perforating arteries, causing a stroke.<xref ref-type="bibr" rid="article-135305.r49">[49]</xref>&#x000a0;The vasculitic infarcts are usually bilateral and multiple, mostly affecting the periventricular area, basal nuclei, and internal capsule. Magnetic resonance&#x000a0;angiography helps delineate vascular narrowing in cerebral infarction territories.<xref ref-type="bibr" rid="article-135305.r50">[50]</xref>&#x000a0;Diffusion-weighted imaging is an advanced MRI technique that accurately&#x000a0;identifies TBM-related cerebral vasculitis and varying stroke stages.<xref ref-type="bibr" rid="article-135305.r51">[51]</xref></p>
        <p>Tuberculomas are visible as discrete, single, or numerous ring-enhancing lesions with marked perilesional&#x000a0;edema&#x000a0;commonly located at the corticomedullary junction. (see<bold> Image. </bold>Brain Tuberculoma on MRI).&#x000a0;Tuberculomas&#x000a0;may&#x000a0;appear differently on CT scans&#x000a0;depending on their maturation stage, presenting as either noncaseating or solidly caseating lesions.&#x000a0;CT may also demonstrate caseating masses with central liquefication or calcification (target sign).<xref ref-type="bibr" rid="article-135305.r52">[52]</xref><xref ref-type="bibr" rid="article-135305.r53">[53]</xref></p>
        <p>MRI&#x000a0;often shows&#x000a0;hypointensities&#x000a0;on T1W and hyperintensities&#x000a0;on T2W images. Postcontrast images delineate&#x000a0;either&#x000a0;ring-shaped or homogeneous disc-shaped enhancement (see&#x000a0;<bold>Image</bold>. Brain Tuberculoma on Magnetic Resonance Imaging). Tuberculomas'&#x000a0;unique metabolite pattern on magnetic resonance spectroscopy may differentiate&#x000a0;them&#x000a0;from metastases and gliomas. A complete and regular peripheral hypointense ring in susceptibility-weighted imaging (SWI) favors the diagnosis of tuberculomas.<xref ref-type="bibr" rid="article-135305.r54">[54]</xref></p>
        <p>Tuberculous myelitis may be visible as diffuse cord swelling with&#x000a0;an altered signal on MRI.&#x000a0;Phase-contrast MRI is the technique of choice for&#x000a0;identifying&#x000a0;spinal subarachnoid space obliteration, dural thickening, paraspinal exudates, cauda equina nerve root clumps, CSF loculations, cord infarction,&#x000a0;and&#x000a0;syringomyelia in spinal arachnoiditis.<xref ref-type="bibr" rid="article-135305.r55">[55]</xref><xref ref-type="bibr" rid="article-135305.r56">[56]</xref></p>
      </sec>
      <sec id="article-135305.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Considering&#x000a0;CNS-TB's high mortality and morbidity rates and various diagnostic challenges, empiric treatment with antituberculous therapy (ATT) and adjunctive corticosteroids may commence based on strong clinical suspicion.&#x000a0;Patients must be closely monitored for prompt&#x000a0;treatment of adverse drug reactions and disease-related complications. No randomized clinical trials can ascertain the most favorable drug combination, dosage, and duration for treating this condition. Various guidelines&#x000a0;recommend different treatment regimens.<xref ref-type="bibr" rid="article-135305.r57">[57]</xref><xref ref-type="bibr" rid="article-135305.r58">[58]</xref><xref ref-type="bibr" rid="article-135305.r59">[59]</xref><xref ref-type="bibr" rid="article-135305.r60">[60]</xref>&#x000a0;</p>
        <p>Drug susceptibility data (when available) and clinical response must always be considered regardless of the combination chosen. The optimal treatment duration is uncertain.</p>
        <p>
<bold>Drug-Susceptible Central&#x000a0;Nervous System&#x000a0;Tuberculosis</bold>
</p>
        <p>The current guidelines&#x000a0;recommend&#x000a0;4&#x000a0;orally administered drugs: isoniazid (INH) 5 mg/kg/d, rifampicin (RMP) 10 mg/kg/d, pyrazinamide (PZA) 25 mg/kg/d, and ethambutol (ETB) 15 mg/kg/d for the first&#x000a0;2&#x000a0;months, constituting the intensive phase. The continuation phase includes&#x000a0;INH, RMP, and ETB daily for at least&#x000a0;7&#x000a0;months. PZA and EMB may be discontinued in the maintenance phase. PZA omission&#x000a0;in the intensive phase&#x000a0;warrants extending&#x000a0;treatment to 18 months.&#x000a0;Directly observed therapy short-course, which involves thrice-weekly&#x000a0;drug administration, is currently not the standard of care&#x000a0;for CNS-TB in India.</p>
        <p>INH displays early bactericidal activity.&#x000a0;RMP has excellent sterilizing activity, clearing persistent bacilli. PZA penetrates the&#x000a0;BBB readily. ETB is a weak drug but completes the regimen for drug-susceptible&#x000a0;tuberculosis.&#x000a0;Drugs&#x000a0;that&#x000a0;may&#x000a0;replace ETB&#x000a0;include streptomycin,&#x000a0;levofloxacin,&#x000a0;and&#x000a0;ethionamide. ETB is avoided when the patient's vision is compromised at baseline or cannot be assessed regularly. Streptomycin&#x000a0;is&#x000a0;contraindicated in&#x000a0;pregnancy, kidney impairment,&#x000a0;and hearing loss. Levofloxacin is superior to gatifloxacin or ciprofloxacin.<xref ref-type="bibr" rid="article-135305.r61">[61]</xref>&#x000a0;Higher RMP or levofloxacin doses are not associated with better survival.<xref ref-type="bibr" rid="article-135305.r62">[62]</xref></p>
        <p>OCA management continues to be a challenge. The response is usually disappointing,&#x000a0;and pulse corticosteroids, thalidomide, and hyaluronidase have been tried with inconsistent outcomes. Neurosurgical intervention and its optimum timing are debatable. Paradoxical OCA also has a variable response.<xref ref-type="bibr" rid="article-135305.r63">[63]</xref></p>
        <p>
<bold>Drug-Resistant&#x000a0;Central Nervous System&#x000a0;Tuberculosis</bold>
</p>
        <p>The guidelines for&#x000a0;managing drug-resistant CNS-TB are similar to those for PTB. The key principle involves never adding a single drug to a failing regimen. Management is challenging due to the huge number of drugs with overlapping&#x000a0;adverse drug reaction profiles. The newer agents, bedaquiline&#x000a0;and&#x000a0;delamanid, received accelerated approvals for PTB but not&#x000a0;CNS-TB.<xref ref-type="bibr" rid="article-135305.r64">[64]</xref></p>
        <p>
<bold>Tuberculomas</bold>
</p>
        <p>International guidelines recommend treating tuberculomas with standard ATT for CNS-TB for 9&#x000a0;to 12 months.<xref ref-type="bibr" rid="article-135305.r65">[65]</xref><xref ref-type="bibr" rid="article-135305.r66">[66]</xref>&#x000a0;Clinical improvement and radiological clearance are observed in 90% and 80% of patients, respectively, by&#x000a0;9&#x000a0;months. Complete resolution depends upon the lesion's initial size.&#x000a0;Tuberculomas&#x000a0;smaller than 2.5&#x000a0;cm resolve in 5 to 8&#x000a0;months, while 50% of lesions larger than 2.5&#x000a0;cm take over 12&#x000a0;months to disappear.<xref ref-type="bibr" rid="article-135305.r67">[67]</xref>&#x000a0;Additionally, guidelines recommend that every patient should receive adjunctive steroids, especially in the presence of paradoxical responses.<xref ref-type="bibr" rid="article-135305.r68">[68]</xref>&#x000a0;Surgical intervention is indicated in patients unresponsive to medical management or&#x000a0;with raised intracranial pressure.<xref ref-type="bibr" rid="article-135305.r65">[65]</xref></p>
        <p>
<bold>Spinal Arachnoiditis</bold>
</p>
        <p>Spinal&#x000a0;tuberculosis is managed similarly to other EPTB forms.&#x000a0;Most international guidelines recommend daily therapy for 6 to 9 months, possibly extending to 24 months if the patient's response is unsatisfactory.<xref ref-type="bibr" rid="article-135305.r69">[69]</xref>&#x000a0;The conservative approach generally has functional outcomes similar to&#x000a0;those of&#x000a0;surgical treatment. Decompression surgery should be considered in&#x000a0;individuals with progressive IRIS-unrelated neurological deficits.<xref ref-type="bibr" rid="article-135305.r70">[70]</xref><xref ref-type="bibr" rid="article-135305.r71">[71]</xref></p>
        <p>
<bold>Anti-Inflammatory Drugs&#x000a0;and Supportive Therapy</bold>
</p>
        <p>The use of adjunctive steroid therapy in TBM management remains an area of ongoing debate. A recent meta-analysis identified clinical benefits when dexamethasone was combined with standard&#x000a0;ATT regimens&#x000a0;for treating TBM.<xref ref-type="bibr" rid="article-135305.r72">[72]</xref>&#x000a0;Few robust, prospective randomized control studies provide definitive data on adjunctive steroid therapy's efficacy in this setting. Thwaites&#x000a0;et al's&#x000a0;randomized study found that&#x000a0;adjunctive steroid therapy provided a survival benefit but did not prevent TBM-associated disability.<xref ref-type="bibr" rid="article-135305.r73">[73]</xref></p>
        <p>Donovan&#x000a0;et al's&#x000a0;recent, large randomized study found no survival benefit to&#x000a0;using adjunctive dexamethasone in TBM treatment in patients with HIV.<xref ref-type="bibr" rid="article-135305.r74">[74]</xref>&#x000a0;Steroids are generally recommended for all TBM stages, except in stage 1 (mild disease), where the clinician may use&#x000a0;their judgment.&#x000a0;Dexamethasone's daily dose is 0.6&#x000a0;mg/kg/d&#x000a0;in children and 0.4&#x000a0;mg/kg/d in adults. Prednisolone is an alternative used in doses of 2&#x000a0;to 4&#x000a0;mg/kg/d&#x000a0;in children and 2.5&#x000a0;mg/kg/d in adults for a minimum of 4 weeks, followed by gradual tapering over the next&#x000a0;4&#x000a0;weeks.<xref ref-type="bibr" rid="article-135305.r75">[75]</xref>&#x000a0;Steroids have been shown to improve survival in TBM but probably do not prevent residual neurologic deficits and severe disability.<xref ref-type="bibr" rid="article-135305.r76">[76]</xref>&#x000a0;</p>
        <p>Thalidomide's anti-inflammatory properties may be used to aid in recovering vision in OCA and IRIS cases.<xref ref-type="bibr" rid="article-135305.r77">[77]</xref>&#x000a0;Infliximab has also been shown to reduce brain inflammation in TBM with paradoxical reactions.<xref ref-type="bibr" rid="article-135305.r78">[78]</xref>&#x000a0;Aspirin has&#x000a0;demonstrated a reduced&#x000a0;3-month stroke-related mortality rate in adults with TBM.<xref ref-type="bibr" rid="article-135305.r79">[79]</xref>&#x000a0;Neurocritical management of CNS-TB is also essential to interprofessional care.<xref ref-type="bibr" rid="article-135305.r80">[80]</xref>&#x000a0;Besides managing seizures and ischemic stroke, TBM-induced hyponatremia requires careful administration of oral salt, intravenous hypertonic saline, or, in resistant cases,&#x000a0;fludrocortisone.<xref ref-type="bibr" rid="article-135305.r81">[81]</xref><xref ref-type="bibr" rid="article-135305.r82">[82]</xref></p>
        <p>
<bold>Immune Reconstitution Inflammatory Syndrome</bold>
</p>
        <p>Clinical or radiological&#x000a0;deterioration&#x000a0;may occur several weeks after ATT initiation in approximately one-third of patients with CNS-TB&#x000a0;due to an aberrant immune response.<xref ref-type="bibr" rid="article-135305.r83">[83]</xref>&#x000a0;Significant IRIS predictors include HIV coinfection, younger age, female&#x000a0;sex, and shorter illness duration.<xref ref-type="bibr" rid="article-135305.r84">[84]</xref>&#x000a0;TB-IRIS is suspected when patients who initially improve on ATT begin demonstrating&#x000a0;worsening symptoms, tuberculomas with increasing size or number on imaging, or OCA aggravation.&#x000a0;No test currently exists to&#x000a0;confirm&#x000a0;TB-IRIS.<xref ref-type="bibr" rid="article-135305.r85">[85]</xref><xref ref-type="bibr" rid="article-135305.r86">[86]</xref>&#x000a0;</p>
        <p>IRIS is believed to result from a delayed type-IV hypersensitivity reaction triggered by the significant release of mycobacterial antigens and increased&#x000a0;tumor necrosis factor-&#x003b1; and CSF lymphocytes or protein levels. IRIS&#x000a0;manifests with&#x000a0;CN deficits due to nerve entanglement&#x000a0;with&#x000a0;inflammatory exudates.&#x000a0;Conditions like communicating hydrocephalus, spinal arachnoiditis, and syringomyelia may also develop. However, the clinician's judgment is crucial in excluding other infections or potential treatment failure.</p>
        <p>
<bold>HIV Coinfection</bold>
</p>
        <p>Patients with HIV&#x000a0;and TBM&#x000a0;naive to antiretroviral therapy (ART) should begin ART 8 to 10 weeks after starting ATT. This sequence&#x000a0;helps avert early TB-associated IRIS&#x000a0;and its potentially fatal neurologic complications.&#x000a0;ATT and ART coadministration in patients with HIV and CNS-TB is often complicated by numerous drug interactions and higher&#x000a0;adverse drug reaction rates.<xref ref-type="bibr" rid="article-135305.r87">[87]</xref>&#x000a0;</p>
        <p>
<bold>Shunt Surgery in&#x000a0;Tuberculous Meningitis</bold>
</p>
        <p>Communicating hydrocephalus is initially managed with corticosteroids, the carbonic anhydrase inhibitor&#x000a0;acetazolamide, and osmotic diuretics&#x000a0;like&#x000a0;mannitol and glycerol.&#x000a0;Temporary external ventricular drainage is&#x000a0;also used for CSF drainage.<xref ref-type="bibr" rid="article-135305.r88">[88]</xref>&#x000a0;Endoscopic third ventriculostomy (ETV) has been reported to have a success rate of 73% to 89%.<xref ref-type="bibr" rid="article-135305.r89">[89]</xref>&#x000a0;ETV has fewer complications and may be more beneficial&#x000a0;than&#x000a0;ventriculoperitoneal&#x000a0;shunt (VPS) placement. However, ETV&#x000a0;is likely to fail during the illness' initial stages,&#x000a0;in which case, VPS surgery may be performed.<xref ref-type="bibr" rid="article-135305.r90">[90]</xref><xref ref-type="bibr" rid="article-135305.r91">[91]</xref>. The outcome of patients treated with&#x000a0;VPS&#x000a0;placement depends considerably on the TBM clinical stage.<xref ref-type="bibr" rid="article-135305.r92">[92]</xref>&#x000a0;</p>
        <p>Vellore and modified Vellore grading systems have been validated for patients with TBM with hydrocephalus to aid in surgical decision-making and predict the success of&#x000a0;VPS&#x000a0;surgery and ETV. The grades vary from 1 to 4, increasing in disease severity. The modified version incorporates the Glasgow Coma Scale score. The management of patients&#x000a0;with&#x000a0;grade 4 TBM is still contentious.<xref ref-type="bibr" rid="article-135305.r93">[93]</xref></p>
      </sec>
      <sec id="article-135305.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>TBM presents a significant diagnostic challenge due to its broad range of potential mimics. Meticulous exclusion of other causes of chronic meningitis or meningoencephalitis is crucial, especially in immunocompromised individuals. Conditions such as fungal meningitis (particularly cryptococcal meningitis), neurobrucellosis, neurosyphilis, neuroborreliosis, and neurosarcoidosis may mimic TBM. Partially treated bacterial meningitis, neoplastic meningitis, or systemic inflammation involving the CNS should also be considered in&#x000a0;appropriate&#x000a0;clinical settings. Neuroradiology and neuropathology&#x000a0;are pivotal in aiding clinicians in these diagnostic challenges.</p>
        <p>Tuberculoma&#x000a0;has similar clinical features and radiological appearance&#x000a0;as neurocysticercosis, cryptococcoma, CNS lymphoma, and primary or metastatic brain tumor. Focal encephalitides like herpes simplex and parameningeal infections like brain abscesses&#x000a0;may occasionally behave similarly to CNS tuberculoma. CNS toxoplasmosis requires careful consideration in cases of HIV coinfection.</p>
        <p>Spinal arachnoiditis needs to be differentiated&#x000a0;from an intradural spinal tuberculoma, extradural compressive myelopathy due to tuberculous spondylitis with paravertebral cold abscess, noncompressive acute transverse myelitis, and Guillain-Barre syndrome. Cytomegalovirus polyradiculopathy can confuse the picture in people with HIV.</p>
      </sec>
      <sec id="article-135305.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Developments in the fields of host immune responses, pathogenesis, and&#x000a0;tuberculosis diagnosis and treatment are happening globally.<xref ref-type="bibr" rid="article-135305.r94">[94]</xref>&#x000a0;Emerging techniques&#x000a0;for rapid TBM diagnosis include measuring new biomarkers like CSF lactate, mNGS, cell-free DNA analysis, clustered regularly interspaced short palindromic repeats (CRISPR)&#x000a0;technology for detecting low MTB levels in CSF, and peripheral blood microRNA detection using transcriptomic techniques.<xref ref-type="bibr" rid="article-135305.r95">[95]</xref>&#x000a0;Human genetic polymorphisms that can explain the heterogeneity of host immune response to anti-inflammatory therapies are being identified. Genomic and metabolomic studies are determining&#x000a0;survival-predicting CSF biomarkers (&#x003b1;&#x003b2; T-cells, natural killer cells, and pro-resolving mediators) that may be used to tailor and individualize therapy.<xref ref-type="bibr" rid="article-135305.r96">[96]</xref><xref ref-type="bibr" rid="article-135305.r97">[97]</xref></p>
        <p>Advanced imaging techniques and sequences like 3-dimensional magnetization-prepared rapid gradient-echo are being studied to better delineate brain lesions. Phase-contrast MRI is another novel and sensitive technique&#x000a0;that helps&#x000a0;assess altered CSF flow dynamics in patients with TBM.<xref ref-type="bibr" rid="article-135305.r98">[98]</xref>&#x000a0;</p>
        <p>Novel promising drugs such as linezolid, bedaquiline, and pretomanid are being tested in various combinations, especially in highly drug-resistant&#x000a0;MTB therapy.<xref ref-type="bibr" rid="article-135305.r99">[99]</xref>&#x000a0;Clinical trials currently examine the effectiveness of high-dose RIF and fluoroquinolones. A combination of intravenous INH, high-dose RIF, and ETB are also in the pipeline.<xref ref-type="bibr" rid="article-135305.r100">[100]</xref>&#x000a0;</p>
        <p>Aspirin is being investigated as an adjunctive treatment to reduce infarction incidence&#x000a0;due to its ability to&#x000a0;inhibit CSF thromboxane A2 and upregulate pre-resolvins.<xref ref-type="bibr" rid="article-135305.r101">[101]</xref>&#x000a0;Adjunctive anti-tumor necrosis factor-&#x003b1;, interferon-&#x003b3;,&#x000a0;and&#x000a0;thalidomide have also been tried to modulate host immune response.&#x000a0;Suitable strategies are likewise being designed and implemented to accomplish the End Tuberculosis Strategy's global targets.<xref ref-type="bibr" rid="article-135305.r102">[102]</xref><xref ref-type="bibr" rid="article-135305.r103">[103]</xref></p>
      </sec>
      <sec id="article-135305.s12" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>ATT is generally well tolerated.&#x000a0;However, close follow-up is needed to monitor any adverse drug reactions that may arise due to the drugs' cumulative effects and long&#x000a0;exposure duration.<xref ref-type="bibr" rid="article-135305.r104">[104]</xref>&#x000a0;All&#x000a0;ATT drugs have specific side effects&#x000a0;besides gastrointestinal intolerance and fatigue. Factors such as HIV coinfection, drug resistance, and steroid prescription can exacerbate the problem. INH, RMP, and PZA are all hepatotoxic. INH can also cause peripheral neuropathy, but this reaction may be prevented by pyridoxine supplementation. INH can cause lupus-like symptoms, pellagra, and psychosis in rare instances. RMP discolors the urine and may cause rashes, influenza-like illness, and thrombocytopenia.</p>
        <p>ETB may produce&#x000a0;dose-dependent optic neuritis and peripheral neuropathy. PZA may give rise to various cutaneous reactions, asymptomatic hyperuricemia, and gouty arthritis. Streptomycin is associated with ototoxicity, vertigo, and injection site pain. The novel drug bedaquiline is associated with QT prolongation&#x000a0;on electrocardiography.</p>
        <p>All patients on ATT should have liver monitoring during the initial&#x000a0;8 weeks of treatment.&#x000a0;An&#x000a0;asymptomatic rise in hepatic transaminases is expected at the beginning of therapy.&#x000a0;Hepatotoxic drugs should be replaced with 2nd- or 3rd-line&#x000a0;options if transaminase levels exceed 3&#x000a0;to 5 times the upper limit of normal or serum bilirubin increases beyond&#x000a0;2.5 mg/L.<xref ref-type="bibr" rid="article-135305.r105">[105]</xref><xref ref-type="bibr" rid="article-135305.r106">[106]</xref></p>
      </sec>
      <sec id="article-135305.s13" sec-type="Staging">
        <title>Staging</title>
        <p>TBM is classified into clinical stages based on illness severity when treatment begins. These stages help prognosticate and decide on therapy.<xref ref-type="bibr" rid="article-135305.r107">[107]</xref><xref ref-type="bibr" rid="article-135305.r108">[108]</xref>&#x000a0;The&#x000a0;TBM stages are defined as follows:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage I: The patient is alert and conscious&#x000a0;with no focal neurological signs or hydrocephalus.</p>
          </list-item>
          <list-item>
            <p>Stage II: The patient is confused or irritable&#x000a0;and has few focal signs, such as CN palsies or hemiparesis.</p>
          </list-item>
          <list-item>
            <p>Stage III: The patient is comatose with or without dense neurological deficit and may be in decerebrate or decorticate posturing.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-135305.s14" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>CNS-TB's prognosis is dismal even after therapy. TBM's mortality ranges between 9.8%&#x000a0;and 57%,&#x000a0;as it is associated with distressing levels of neurologic sequelae that disproportionately afflict children.<xref ref-type="bibr" rid="article-135305.r109">[109]</xref>&#x000a0;Various mortality and neurological morbidity predictors&#x000a0;have been identified, including age, symptom duration, Glasgow Coma Scale score, absence of headache, CSF protein level, arachnoiditis extent, presence of complications, and Medical Research Council staging at presentation.<xref ref-type="bibr" rid="article-135305.r110">[110]</xref></p>
      </sec>
      <sec id="article-135305.s15" sec-type="Complications">
        <title>Complications</title>
        <p>CNS-TB can be lethal or cause devastating complications. The initial complications&#x000a0;arise from&#x000a0;pachymeningitis, leading to hydrocephalus, OCA-related visual loss, focal neurological deficits, stroke, arteritis-induced hemiplegias, cerebral edema, tuberculoma- or abscess-induced seizures, and diabetes insipidus or syndrome of inappropriate antidiuretic hormone secretion. Myelitis complicates TBM in 10% of cases and is an independent&#x000a0;predictor of poor outcomes.<xref ref-type="bibr" rid="article-135305.r111">[111]</xref>&#x000a0;Around&#x000a0;10% to 30% of patients with TBM&#x000a0;develop long-term residual neurologic deficits, including the above complications,&#x000a0;besides learning disabilities, dementia, endocrine syndromes, and gait disturbances.</p>
      </sec>
      <sec id="article-135305.s16" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>TBM necessitates intensive rehabilitation&#x000a0;and optimal medical treatment to reduce disability and facilitate recovery. Rehabilitation should commence during hospitalization or in the intensive care unit and extend into the home postdischarge.&#x000a0;Rehabilitative efforts should encompass multimodal sensory stimulation to enhance brain function recovery, scheduled posturing and positioning to prevent immobilization complications, passive and active range of motion exercises to maintain muscle strength, and chest physiotherapy to mitigate pneumonia and aspiration risks. Long-term rehabilitation is essential for patients with lingering neurological impairments<xref ref-type="bibr" rid="article-135305.r112">[112]</xref></p>
      </sec>
      <sec id="article-135305.s17" sec-type="Consultations">
        <title>Consultations</title>
        <p>Specialists in the following&#x000a0;disciplines should be consulted for comprehensive CNS-TB management:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious disease</p>
          </list-item>
          <list-item>
            <p>Neuroradiology</p>
          </list-item>
          <list-item>
            <p>Neurology</p>
          </list-item>
          <list-item>
            <p>Neurosurgery</p>
          </list-item>
          <list-item>
            <p>Ophthalmology</p>
          </list-item>
          <list-item>
            <p>Physiotherapy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-135305.s18" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients and their caregivers&#x000a0;must be educated about medication compliance, as CNS-TB requires prolonged treatment. These individuals&#x000a0;must be enlightened about the potential disease- and treatment-related complications.&#x000a0;Patients and their families should be counseled for regular hospital visits, investigations, and close follow-ups to ensure disease resolution and prevent&#x000a0;adverse drug reactions.</p>
      </sec>
      <sec id="article-135305.s19" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>
<bold>Pearls</bold>
</p>
        <p>CNS-TB poses a diagnostic and therapeutic challenge due to its paucibacillary nature and diverse clinical manifestations. Diagnosis hinges on a combination of clinical suspicion, imaging,&#x000a0;CSF analysis, and molecular techniques like Xpert MTB/RIF. Early and accurate diagnosis is crucial, as delayed&#x000a0;treatment may lead to serious morbidity and mortality.&#x000a0;Treatment involves&#x000a0;ATT and adjunctive corticosteroids, with surgical intervention reserved for specific complications. Monitoring for paradoxical reactions and IRIS is essential during treatment. Long-term neurorehabilitation may be necessary for patients with residual neurological deficits. Interprofessional collaboration is paramount for optimizing outcomes in CNS-TB management.</p>
        <p>
<bold>Other Issues</bold>
</p>
        <p>A discussion of spinal tuberculosis is relevant in this section due to its overlapping neurological presentations with CNS-TB. Spinal tuberculosis, a subset of skeletal tuberculosis, manifests as spondylodiscitis or spondylitis without intervertebral disk involvement.<xref ref-type="bibr" rid="article-135305.r113">[113]</xref>&#x000a0;In adults, intervertebral disk involvement often results from contiguous spread from infected vertebrae.&#x000a0;In children, hematogenous spread may lead to TB diskitis due to the area's rich vascular supply.&#x000a0;Pott disease is characterized by osteomyelitis and arthritis and typically affects multiple vertebrae.&#x000a0;The condition produces progressive vertebral destruction, anterior collapse, kyphotic or gibbous deformity (in thoracic vertebrae), paraspinal cold abscess formation, and spinal canal narrowing. These complications can culminate in various neurological deficits, with paraplegia being the most devastating.<xref ref-type="bibr" rid="article-135305.r114">[114]</xref>&#x000a0;</p>
        <p>Early-onset paraplegia may occur due to mechanical compression by tuberculous debris, bone or disk sequestrum, tuberculomas, granulomas, or abscess in extradural, intradural, or intramedullary regions, myelitis with cord edema, meningeal inflammation, and anterior spinal artery thrombosis&#x000a0;with cord infarction. Frank infarction is rare&#x000a0;since the smaller end-arteries are involved.<xref ref-type="bibr" rid="article-135305.r115">[115]</xref></p>
        <p>Late-onset paraplegia in severe kyphosis may result from cord transection by a transverse bony ridge or dural fibrosis with cord encasement and, occasionally, syrinx formation. Paraspinal abscesses may mechanically compress the cord depending on their location. Retropharyngeal abscesses may cause dysphagia and respiratory distress.&#x000a0;Mediastinal lesions can track down to the trachea, esophagus, or pleural cavity. Tuberculous abscesses may present as fusiform or bulbous paravertebral swelling in the thoracic region and groin or medial thigh bulging in the lumbar area.</p>
        <p>For neuroimaging, spinal CT scans offer detailed bony information, while MRI is essential for evaluating soft tissue components (see&#x000a0;<bold>Images</bold>. Spinal Cord Tuberculoma, Pott Spine). Spinal&#x000a0;tuberculosis typically spares the intervertebral disc, shows vertebral endplate rarefaction and&#x000a0;anterior vertebral wedging, and may present with paravertebral abscesses. Neuroimaging-guided needle biopsy&#x000a0;of the involved vertebral body is the diagnostic gold standard. Pott spine treatment involves standard ATT, with the continuation phase potentially extending up to 18 months. Surgery for&#x000a0;this condition is indicated in cases of neurological deficits, large paravertebral abscesses, and spinal instability.</p>
      </sec>
      <sec id="article-135305.s20" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>CNS-TB, though rare, profoundly affects both the quantity and quality of life. Screening for active infected cases in high tuberculosis-burden settings may help prevent CNS-TB. Treatment adherence significantly influences outcomes once diagnosed. While most countries have national policies in place, embracing global evidence-based approaches to CNS-TB management is essential for ensuring optimal patient care and support.<xref ref-type="bibr" rid="article-135305.r116">[116]</xref></p>
        <p>CNS-TB requires comprehensive and coordinated team care to enhance patient outcomes. Each team member, including the treating clinician, infectious disease specialist, neuroradiologist, neurologist, neurosurgeon, ophthalmologist, nurse, and pharmacist, holds individual and collaborative responsibilities. Nurses are crucial for overall patient care, while pharmacists, especially infectious disease-specialized pharmacists,&#x000a0;are vital&#x000a0;during drug selection, medication reconciliation, dosing regimens, adjustments, and patient counseling.<xref ref-type="bibr" rid="article-135305.r117">[117]</xref><xref ref-type="bibr" rid="article-135305.r118">[118]</xref> Effective communication with prescribing clinicians is essential for pharmacists to modify therapy appropriately in response to patient status changes.</p>
        <p>Effective communication and collaboration&#x000a0;within the healthcare team are essential for shared decision-making to reduce complications and expedite recovery in critically ill patients.<xref ref-type="bibr" rid="article-135305.r119">[119]</xref> Improved&#x000a0;infection control modalities and surveillance are necessary to screen and diagnose patients efficiently and provide interprofessional services to affected individuals.</p>
        <p>Most countries release evidence-based guidelines for managing PTB and EPTB without considering each patient's unique circumstances, geographic location, and healthcare setting. Clinical decisions&#x000a0;must be individualized&#x000a0;to enhance health outcomes.<xref ref-type="bibr" rid="article-135305.r120">[120]</xref></p>
      </sec>
      <sec id="article-135305.s21">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135305&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135305">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/cns-tuberculosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=135305">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/135305/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=135305">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-135305.s22">
        <fig id="article-135305.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tuberculous Meningitis Histopathology. This slide shows caseous necrotic centers surrounded by epithelioid and Langhans giant cells. Contributed by Syed Rafay Zaidi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tuberculoma-Edited" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s23">
        <fig id="article-135305.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Tuberculoma on Funduscopy. Color photo and fluorescein angiography of a choroidal granuloma (tuberculoma) in a patient with tuberculous uveitis. Contributed by Ayman Elnahry, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Color__photo__and__FA__tuberculoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s24">
        <fig id="article-135305.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Tuberculous Meningitis on Computed Tomography Contributed by Steve Lange, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tuberculous__meningitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s25">
        <fig id="article-135305.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Tuberculous Meningitis on Magnetic Resonance Imaging Contributed by Steve Lange, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="meningitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s26">
        <fig id="article-135305.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Spinal Cord Tuberculoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tuberculoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s27">
        <fig id="article-135305.image.f6" position="float" orientation="portrait">
          <caption>
            <p>Pott Spine Contributed by Sunil Munakomi</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="TB" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s28">
        <fig id="article-135305.image.f7" position="float" orientation="portrait">
          <caption>
            <p>Brain Tuberculoma on Magnetic Resonance Imaging Contributed by S Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CNS__TB" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-135305.s29">
        <fig id="article-135305.image.f8" position="float" orientation="portrait">
          <caption>
            <p>Pulmonary Tuberculosis. This image shows an anteroposterior chest x-ray of a patient diagnosed with advanced bilateral pulmonary tuberculosis. The x-ray reveals the presence of bilateral pulmonary infiltrate (white triangles), and "caving formation" (black arrows) present in the right apical region. The&#x000a0;findings suggest&#x000a0;far-advanced tuberculosis. Centers for Disease Control and Prevention&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tuberculosis-x-ray-1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-135305.s30">
        <title>References</title>
        <ref id="article-135305.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erdem</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guven</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hargreaves</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shehata</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pernicova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bastakova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Namani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harxhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roganovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lakatos</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Uysal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sipahi</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Crisan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miftode</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stebel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jegorovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Feh&#x000e9;r</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jekkel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pandak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Moravveji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khalifa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Musabak</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jouhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oztoprak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Argemi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Baldeyrou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellaud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moroti</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tekin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Canestri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x0010c;alki&#x00107;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pratic&#x000f2;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yilmaz-Karadag</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaptan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bossi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duissenova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shopayeva</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Utaganov</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Grgic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ersoz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>AKL</given-names>
              </name>
              <name>
                <surname>Lung</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Bruzsa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Radic</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Kahraman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Momen-Heravi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulzhanova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rigo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Konkayeva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smagulova</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ahmetagic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Porobic-Jahic</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moradi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cag</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bohr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Artuk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Amsilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gul</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Cascio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanzafame</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nassar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The burden and epidemiology of community-acquired central nervous system infections: a multinational study.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1595</fpage>
            <page-range>1595-1611</page-range>
            <pub-id pub-id-type="pmid">28397100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonard</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Central Nervous System Tuberculosis.</article-title>
            <source>Microbiol Spectr</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28281443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ingole</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rizvi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Spectrum of central nervous system tuberculosis: An experience from a large tertiary care institution of India.</article-title>
            <source>Indian J Tuberc</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-57</page-range>
            <pub-id pub-id-type="pmid">30797283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wicke</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Foerch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weidauer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features.</article-title>
            <source>Clin Neuroradiol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-18</page-range>
            <pub-id pub-id-type="pmid">30225516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>T&#x000f6;r&#x000f6;k</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: advances in diagnosis and treatment.</article-title>
            <source>Br Med Bull</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <page-range>117-31</page-range>
            <pub-id pub-id-type="pmid">25693576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Rohlwink</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Proust</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Figaji</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The pathogenesis of tuberculous meningitis.</article-title>
            <source>J Leukoc Biol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>105</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-280</page-range>
            <pub-id pub-id-type="pmid">30645042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guleria</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kavitha</surname>
              </name>
            </person-group>
            <article-title>Central nervous system tuberculosis.</article-title>
            <source>Indian J Tuberc</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-9</page-range>
            <pub-id pub-id-type="pmid">25241567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Estiasari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maharani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sucipto</surname>
              </name>
              <name>
                <surname>Lestari</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Yunus</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Yunihastuti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Karyadi</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Oei</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Timan</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Wulandari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wahyuningsih</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Adawiyah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kurniawan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mulyadi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karuniawati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaya</surname>
                <given-names>UA</given-names>
              </name>
              <name>
                <surname>Safari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van Laarhoven</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alisjahbana</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaidir</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ganiem</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lastri</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Aye Myint</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>379</fpage>
            <page-range>379-388</page-range>
            <pub-id pub-id-type="pmid">30564491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patkar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Narang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yanamandala</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lawande</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>GV</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system tuberculosis: pathophysiology and imaging findings.</article-title>
            <source>Neuroimaging Clin N Am</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>677</fpage>
            <page-range>677-705</page-range>
            <pub-id pub-id-type="pmid">23122262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chin</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: A neglected tropical disease?</article-title>
            <source>Neurol Clin Pract</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-154</page-range>
            <pub-id pub-id-type="pmid">31041130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deutsch-Feldman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pratt</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis - United States, 2020.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2021</year>
            <month>Mar</month>
            <day>26</day>
            <volume>70</volume>
            <issue>12</issue>
            <fpage>409</fpage>
            <page-range>409-414</page-range>
            <pub-id pub-id-type="pmid">33764959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filardo</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Pratt</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis - United States, 2021.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2022</year>
            <month>Mar</month>
            <day>25</day>
            <volume>71</volume>
            <issue>12</issue>
            <fpage>441</fpage>
            <page-range>441-446</page-range>
            <pub-id pub-id-type="pmid">35324877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rieder</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Snider</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Cauthen</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Extrapulmonary tuberculosis in the United States.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>141</volume>
            <issue>2</issue>
            <fpage>347</fpage>
            <page-range>347-51</page-range>
            <pub-id pub-id-type="pmid">2301852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moule</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cirillo</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycobacterium tuberculosis</italic> Dissemination Plays a Critical Role in Pathogenesis.</article-title>
            <source>Front Cell Infect Microbiol</source>
            <year>2020</year>
            <volume>10</volume>
            <fpage>65</fpage>
            <pub-id pub-id-type="pmid">32161724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dastur</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Manghani</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Udani</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Pathology and pathogenetic mechanisms in neurotuberculosis.</article-title>
            <source>Radiol Clin North Am</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>733</fpage>
            <page-range>733-52</page-range>
            <pub-id pub-id-type="pmid">7610242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cherian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ajitha</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Iype</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Divya</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Neurotuberculosis: an update.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>121</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-21</page-range>
            <pub-id pub-id-type="pmid">33400226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhargava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tandon</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis--a CT study.</article-title>
            <source>Br J Radiol</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>55</volume>
            <issue>651</issue>
            <fpage>189</fpage>
            <page-range>189-96</page-range>
            <pub-id pub-id-type="pmid">7066619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kent</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Crowe</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Yung</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Mijch</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: a 30-year review.</article-title>
            <source>Clin Infect Dis</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>987</fpage>
            <page-range>987-94</page-range>
            <pub-id pub-id-type="pmid">8110957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Walia</surname>
                <given-names>BN</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis (T.B.M.)(a clinical study of 232 cases).</article-title>
            <source>J Assoc Physicians India</source>
            <year>1977</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>633</fpage>
            <page-range>633-9</page-range>
            <pub-id pub-id-type="pmid">612660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvador</surname>
                <given-names>GLO</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>ACN</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Leitao</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>BCA</given-names>
              </name>
              <name>
                <surname>Neto</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system and spinal cord tuberculosis: Revisiting an important disease.</article-title>
            <source>Clin Imaging</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>69</volume>
            <fpage>158</fpage>
            <page-range>158-168</page-range>
            <pub-id pub-id-type="pmid">32853843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kocen</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neurological complications of tuberculosis: some unusual manifestations.</article-title>
            <source>Q J Med</source>
            <year>1970</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>153</issue>
            <fpage>17</fpage>
            <page-range>17-30</page-range>
            <pub-id pub-id-type="pmid">5427330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berenguer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laguna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Adrados</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-LaHoz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bouza</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis in patients infected with the human immunodeficiency virus.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Mar</month>
            <day>05</day>
            <volume>326</volume>
            <issue>10</issue>
            <fpage>668</fpage>
            <page-range>668-72</page-range>
            <pub-id pub-id-type="pmid">1346547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;cha&#x000ef;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bouchaud</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: Challenges in diagnosis and management.</article-title>
            <source>Rev Neurol (Paris)</source>
            <year>2019</year>
            <season>Sep-Oct</season>
            <volume>175</volume>
            <issue>7-8</issue>
            <fpage>451</fpage>
            <page-range>451-457</page-range>
            <pub-id pub-id-type="pmid">31383464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rohlwink</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>NTH</given-names>
              </name>
              <name>
                <surname>Dooley</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Caws</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Figaji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Savic</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Solomons</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <collab>Tuberculous Meningitis International Research Consortium</collab>
            </person-group>
            <article-title>Tuberculous meningitis.</article-title>
            <source>Nat Rev Neurol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>581</fpage>
            <page-range>581-598</page-range>
            <pub-id pub-id-type="pmid">28884751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marais</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schoeman</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>T&#x000f6;r&#x000f6;k</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Donald</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Marais</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis: a uniform case definition for use in clinical research.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>803</fpage>
            <page-range>803-12</page-range>
            <pub-id pub-id-type="pmid">20822958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Validation of the Uniform Case Definition Criteria for Differentiating Tuberculous Meningitis, Viral Meningitis, and Bacterial Meningitis in Adults.</article-title>
            <source>Infect Chemother</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-190</page-range>
            <pub-id pub-id-type="pmid">31270999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munakomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grasso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chapagain</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Multi-spectral Pattern of Clinical Presentation and the Resultant Outcome in Central Nervous System Tuberculosis: A Single Center Study on the Ubiquitous Pathogen.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2020</year>
            <volume>1271</volume>
            <fpage>29</fpage>
            <page-range>29-35</page-range>
            <pub-id pub-id-type="pmid">31994016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Saxena</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmological manifestation in patients of tuberculous meningitis.</article-title>
            <source>QJM</source>
            <year>2019</year>
            <month>Jun</month>
            <day>01</day>
            <volume>112</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-419</page-range>
            <pub-id pub-id-type="pmid">30722057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stadelman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ssebambulidde</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Buller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tugume</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yuquimpo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Boulware</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Bahr</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Cerebrospinal fluid AFB smear in adults with tuberculous meningitis: A systematic review and diagnostic test accuracy meta-analysis.</article-title>
            <source>Tuberculosis (Edinb)</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>135</volume>
            <fpage>102230</fpage>
            <pub-id pub-id-type="pmid">35779498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schiller</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dendukuri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dheda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Denkinger</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Steingart</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Xpert<sup>&#x000ae;</sup> MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Aug</month>
            <day>27</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD012768</fpage>
            <pub-id pub-id-type="pmid">30148542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakode</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Siddaiah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Manjunath</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bahubali</surname>
                <given-names>VKH</given-names>
              </name>
            </person-group>
            <article-title>GeneXpert: A Rapid and Supplementary Diagnostic Tool for Tuberculous Meningitis, Experience from Tertiary Neurocenter.</article-title>
            <source>J Neurosci Rural Pract</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-210</page-range>
            <pub-id pub-id-type="pmid">35694081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boehme</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Nabeta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hillemann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nicol</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Shenai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krapp</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tahirli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blakemore</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rustomjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Milovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Persing</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ruesch-Gerdes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gotuzzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Rapid molecular detection of tuberculosis and rifampin resistance.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Sep</month>
            <day>09</day>
            <volume>363</volume>
            <issue>11</issue>
            <fpage>1005</fpage>
            <page-range>1005-15</page-range>
            <pub-id pub-id-type="pmid">20825313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bahr</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Nuwagira</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Cresswell</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Bystrom</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Byamukama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bridge</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Bangdiwala</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Meya</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Denkinger</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Muzoora</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boulware</surname>
                <given-names>DR</given-names>
              </name>
              <collab>ASTRO-CM Trial Team</collab>
            </person-group>
            <article-title>Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-75</page-range>
            <pub-id pub-id-type="pmid">28919338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajput</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sarin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of loop-mediated isothermal amplification assay for extra-pulmonary tuberculosis in Indian population.</article-title>
            <source>J Microbiol Methods</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>158</volume>
            <fpage>59</fpage>
            <page-range>59-65</page-range>
            <pub-id pub-id-type="pmid">30703448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kagimu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Okirworth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bangdiwala</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mugumya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Meya</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Cresswell</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Bahr</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Boulware</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>Nov</month>
            <day>02</day>
            <volume>73</volume>
            <issue>9</issue>
            <fpage>e3428</fpage>
            <page-range>e3428-e3434</page-range>
            <pub-id pub-id-type="pmid">33388751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddiqi</surname>
                <given-names>OK</given-names>
              </name>
              <name>
                <surname>Birbeck</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Ghebremichael</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mubanga</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buback</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kosloff</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ayles</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Atadzhanov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dheda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koralnik</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.</article-title>
            <source>J Clin Microbiol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31189584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leng</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis.</article-title>
            <source>Front Cell Infect Microbiol</source>
            <year>2022</year>
            <volume>12</volume>
            <fpage>788692</fpage>
            <pub-id pub-id-type="pmid">35531329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis-specific antigen stimulated and unstimulated interferon-&#x003b3; for tuberculous meningitis diagnosis: A systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2022</year>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>e0273834</fpage>
            <pub-id pub-id-type="pmid">36040925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A&#x000a0;multi-center, retrospective study in China.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>e24307</fpage>
            <pub-id pub-id-type="pmid">35202495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>QC</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>XP</given-names>
              </name>
            </person-group>
            <article-title>Performance of metagenomic next-generation sequencing in cerebrospinal fluid for diagnosis of tuberculous meningitis.</article-title>
            <source>J Med Microbiol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>73</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">38506717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Sha</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis.</article-title>
            <source>Am J Med Sci</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>344</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-21</page-range>
            <pub-id pub-id-type="pmid">22104430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rana</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Parbhakar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>424</fpage>
            <page-range>424-30</page-range>
            <pub-id pub-id-type="pmid">20347212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhary</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garga</surname>
                <given-names>UC</given-names>
              </name>
            </person-group>
            <article-title>Central Nervous System Tuberculosis: An Imaging Perspective.</article-title>
            <source>Can Assoc Radiol J</source>
            <year>2017</year>
            <month>May</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-170</page-range>
            <pub-id pub-id-type="pmid">28283299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging in tuberculous meningitis.</article-title>
            <source>Neurol India</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>219</fpage>
            <page-range>219-27</page-range>
            <pub-id pub-id-type="pmid">26954796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andronikou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hatherhill</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Douis</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wilmshurst</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Definitive neuroradiological diagnostic features of tuberculous meningitis in children.</article-title>
            <source>Pediatr Radiol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>876</fpage>
            <page-range>876-85</page-range>
            <pub-id pub-id-type="pmid">15378213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Botha</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Candy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Griffith-Richards</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>e38982</fpage>
            <pub-id pub-id-type="pmid">22768055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Paliwal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>719</fpage>
            <page-range>719-29</page-range>
            <pub-id pub-id-type="pmid">21905782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernaerts</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vanhoenacker</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Parizel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Van Goethem</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Van Altena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Laridon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Roeck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coeman</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Schepper</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis of the central nervous system: overview of neuroradiological findings.</article-title>
            <source>Eur Radiol</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>1876</fpage>
            <page-range>1876-90</page-range>
            <pub-id pub-id-type="pmid">12942288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soni</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bathla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cerebrovascular complications in tuberculous meningitis-A magnetic resonance imaging study in 90 patients from a tertiary care hospital.</article-title>
            <source>Neuroradiol J</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-16</page-range>
            <pub-id pub-id-type="pmid">31589101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Predictors of stroke and its significance in the outcome of tuberculous meningitis.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>251</fpage>
            <page-range>251-8</page-range>
            <pub-id pub-id-type="pmid">19560677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shukla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abbas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging.</article-title>
            <source>J Infect</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>298</fpage>
            <page-range>298-306</page-range>
            <pub-id pub-id-type="pmid">18760486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wasay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kheleani</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Moolani</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Zaheer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muzaffar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bakshi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarawari</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma.</article-title>
            <source>J Neuroimaging</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>240</fpage>
            <page-range>240-7</page-range>
            <pub-id pub-id-type="pmid">12889171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bargall&#x000f3;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berenguer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Barrionuevo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ubeda</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bargall&#x000f3;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cardenal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mercader</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The "target sign": is it a specific sign of CNS tuberculoma?</article-title>
            <source>Neuroradiology</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>547</fpage>
            <page-range>547-50</page-range>
            <pub-id pub-id-type="pmid">8880716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parry</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Shaheen</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Feroz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ilyas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI).</article-title>
            <source>Br J Radiol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>91</volume>
            <issue>1091</issue>
            <fpage>20180342</fpage>
            <pub-id pub-id-type="pmid">29987985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord involvement in tuberculous meningitis.</article-title>
            <source>Spinal Cord</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>649</fpage>
            <page-range>649-57</page-range>
            <pub-id pub-id-type="pmid">25896347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord and spinal nerve root involvement (myeloradiculopathy) in tuberculous meningitis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>e404</fpage>
            <pub-id pub-id-type="pmid">25621686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nahid</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Alipanah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cattamanchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Grzemska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Higashi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hopewell</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Keshavjee</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Lienhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Merrifield</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peloquin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Raftery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saukkonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaaf</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Starke</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Vernon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <day>01</day>
            <volume>63</volume>
            <issue>7</issue>
            <fpage>e147</fpage>
            <page-range>e147-e195</page-range>
            <pub-id pub-id-type="pmid">27516382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hemingway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Innes</surname>
                <given-names>J</given-names>
              </name>
              <collab>British Infection Society</collab>
            </person-group>
            <article-title>British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.</article-title>
            <source>J Infect</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-87</page-range>
            <pub-id pub-id-type="pmid">19643501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r59">
          <label>59</label>
          <element-citation publication-type="book">
            <source>WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-susceptible tuberculosis treatment [Internet]</source>
            <publisher-name>World Health Organization</publisher-name>
            <publisher-loc>Geneva</publisher-loc>
            <year>2022</year>
            <pub-id pub-id-type="pmid">35727905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khaparde</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sachdeva</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Paramasivan</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nischal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khatiwada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tharyan</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India.</article-title>
            <source>Indian J Med Res</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>448</fpage>
            <page-range>448-463</page-range>
            <pub-id pub-id-type="pmid">28862176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Bhavnani</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Hammel</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>T&#x000f6;r&#x000f6;k</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Van Wart</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Caws</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dung</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Hien</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Kulawy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>55</volume>
            <issue>7</issue>
            <fpage>3244</fpage>
            <page-range>3244-53</page-range>
            <pub-id pub-id-type="pmid">21502621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heemskerk</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Loc</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Hien</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Dung</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Phong</surname>
                <given-names>le T</given-names>
              </name>
              <name>
                <surname>Vien</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Hien</surname>
                <given-names>NQ</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Caws</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Merson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thinh</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Wolbers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Jan</month>
            <day>14</day>
            <volume>374</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-34</page-range>
            <pub-id pub-id-type="pmid">26760084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peloquin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>The Treatment of Tuberculosis.</article-title>
            <source>Clin Pharmacol Ther</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>110</volume>
            <issue>6</issue>
            <fpage>1455</fpage>
            <page-range>1455-1466</page-range>
            <pub-id pub-id-type="pmid">33837535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.</article-title>
            <source>Drug Dev Res</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-105</page-range>
            <pub-id pub-id-type="pmid">30548290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ganiem</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>van Laarhoven</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system tuberculosis.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2021</year>
            <month>Jun</month>
            <day>01</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>396</fpage>
            <page-range>396-402</page-range>
            <pub-id pub-id-type="pmid">33661159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marais</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Toorn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Manesh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siddiqi</surname>
                <given-names>OK</given-names>
              </name>
              <name>
                <surname>Figaji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schoeman</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Meintjes</surname>
                <given-names>G</given-names>
              </name>
              <collab>Tuberculous Meningitis International Research Consortium</collab>
            </person-group>
            <article-title>Management of intracranial tuberculous mass lesions: how long should we treat for?</article-title>
            <source>Wellcome Open Res</source>
            <year>2019</year>
            <volume>4</volume>
            <fpage>158</fpage>
            <pub-id pub-id-type="pmid">32047859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khatri</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Antil</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saigal</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging spectrum of intracranial tubercular lesions: one disease, many faces.</article-title>
            <source>Pol J Radiol</source>
            <year>2018</year>
            <volume>83</volume>
            <fpage>e524</fpage>
            <page-range>e524-e535</page-range>
            <pub-id pub-id-type="pmid">30800191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su&#x000e1;rez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gruell</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heyckendorf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>F&#x000fc;nger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Unnewehr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>F&#x000e4;tkenheuer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rybniker</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Intensified adjunctive corticosteroid therapy for CNS tuberculomas.</article-title>
            <source>Infection</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-293</page-range>
            <pub-id pub-id-type="pmid">31900872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madhuripan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pandita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hurtado</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Challenges and controversies in the treatment of spinal tuberculosis.</article-title>
            <source>J Clin Tuberc Other Mycobact Dis</source>
            <year>2020</year>
            <month>May</month>
            <volume>19</volume>
            <fpage>100151</fpage>
            <pub-id pub-id-type="pmid">32154388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathod</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Sathe</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Marathe</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>It's Never Too Late: Neurological Outcome of Delayed Decompression in Tuberculosis of Spine.</article-title>
            <source>Global Spine J</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>716</fpage>
            <page-range>716-721</page-range>
            <pub-id pub-id-type="pmid">32875909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yong</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Ahmedy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Engkasan</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Functional Outcomes in Spinal Tuberculosis: A Review of the Literature.</article-title>
            <source>Asian Spine J</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>381</fpage>
            <page-range>381-391</page-range>
            <pub-id pub-id-type="pmid">32951405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Clinical Efficacy of Dexamethasone in the Treatment of Patients with Tuberculous Meningitis: A Meta-Analysis.</article-title>
            <source>Contrast Media Mol Imaging</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>2180374</fpage>
            <pub-id pub-id-type="pmid">35418812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Hoang</surname>
                <given-names>TQ</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>QH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Vu</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Stepniewska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>21</day>
            <volume>351</volume>
            <issue>17</issue>
            <fpage>1741</fpage>
            <page-range>1741-51</page-range>
            <pub-id pub-id-type="pmid">15496623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donovan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Imran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nghia</surname>
                <given-names>HDT</given-names>
              </name>
              <name>
                <surname>Burhan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huong</surname>
                <given-names>DTT</given-names>
              </name>
              <name>
                <surname>Hiep</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>Ngoc</surname>
                <given-names>LHB</given-names>
              </name>
              <name>
                <surname>Thanh</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Thanh</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Wardhani</surname>
                <given-names>ALS</given-names>
              </name>
              <name>
                <surname>Maharani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gasmara</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Hanh</surname>
                <given-names>NHH</given-names>
              </name>
              <name>
                <surname>Oanh</surname>
                <given-names>PKN</given-names>
              </name>
              <name>
                <surname>Estiasari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thu</surname>
                <given-names>DDA</given-names>
              </name>
              <name>
                <surname>Kusumaningrum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dung</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Giang</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>DTM</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>NVV</given-names>
              </name>
              <name>
                <surname>Nguyet</surname>
                <given-names>NTM</given-names>
              </name>
              <name>
                <surname>Geskus</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Thuong</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>Kestelyn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hamers</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <collab>ACT HIV Investigators</collab>
            </person-group>
            <article-title>Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.</article-title>
            <source>N Engl J Med</source>
            <year>2023</year>
            <month>Oct</month>
            <day>12</day>
            <volume>389</volume>
            <issue>15</issue>
            <fpage>1357</fpage>
            <page-range>1357-1367</page-range>
            <pub-id pub-id-type="pmid">37819954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gundamraj</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The Use of Adjunctive Steroids in Central Nervous Infections.</article-title>
            <source>Front Cell Infect Microbiol</source>
            <year>2020</year>
            <volume>10</volume>
            <fpage>592017</fpage>
            <pub-id pub-id-type="pmid">33330135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prasad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids for managing tuberculous meningitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Apr</month>
            <day>28</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD002244</fpage>
            <pub-id pub-id-type="pmid">27121755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoeman</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Andronikou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stefan</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van Toorn</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases.</article-title>
            <source>J Child Neurol</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>822</fpage>
            <page-range>822-8</page-range>
            <pub-id pub-id-type="pmid">20519667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jorge</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Graciela</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pablo</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Luis</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis.</article-title>
            <source>J Clin Rheumatol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>189</fpage>
            <page-range>189-91</page-range>
            <pub-id pub-id-type="pmid">22647865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.</article-title>
            <source>J Neurol Sci</source>
            <year>2010</year>
            <month>Jun</month>
            <day>15</day>
            <volume>293</volume>
            <issue>1-2</issue>
            <fpage>12</fpage>
            <page-range>12-7</page-range>
            <pub-id pub-id-type="pmid">20421121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donovan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Figaji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Imran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Rohlwink</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>The neurocritical care of tuberculous meningitis.</article-title>
            <source>Lancet Neurol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>771</fpage>
            <page-range>771-783</page-range>
            <pub-id pub-id-type="pmid">31109897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagotkar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shanbag</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dasarwar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cerebral salt wasting syndrome following neurosurgical intervention in tuberculous meningitis.</article-title>
            <source>Indian Pediatr</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>598</fpage>
            <page-range>598-601</page-range>
            <pub-id pub-id-type="pmid">18695284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
              <collab>Tuberculous Meningitis International Research Consortium</collab>
            </person-group>
            <article-title>Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis.</article-title>
            <source>Wellcome Open Res</source>
            <year>2019</year>
            <volume>4</volume>
            <fpage>189</fpage>
            <pub-id pub-id-type="pmid">32734004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hermawan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Laarhoven</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Immaculata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Achmad</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Ruslami</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Anwary</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Soetikno</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Ganiem</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>e0241974</fpage>
            <pub-id pub-id-type="pmid">33186351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kohli</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2016</year>
            <month>Jun</month>
            <day>21</day>
            <volume>16</volume>
            <fpage>306</fpage>
            <pub-id pub-id-type="pmid">27329253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Poplin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kasibante</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yuquimpo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gakuru</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cresswell</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Bahr</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease.</article-title>
            <source>Life (Basel)</source>
            <year>2020</year>
            <month>Oct</month>
            <day>29</day>
            <volume>10</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">33138069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Paradoxical reaction in HIV negative tuberculous meningitis.</article-title>
            <source>J Neurol Sci</source>
            <year>2014</year>
            <month>May</month>
            <day>15</day>
            <volume>340</volume>
            <issue>1-2</issue>
            <fpage>26</fpage>
            <page-range>26-36</page-range>
            <pub-id pub-id-type="pmid">24680563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kadhiravan</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>HIV-TB co-infection: epidemiology, diagnosis &#x00026; management.</article-title>
            <source>Indian J Med Res</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>121</volume>
            <issue>4</issue>
            <fpage>550</fpage>
            <page-range>550-67</page-range>
            <pub-id pub-id-type="pmid">15817963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajshekhar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Management of hydrocephalus in patients with tuberculous meningitis.</article-title>
            <source>Neurol India</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <page-range>368-74</page-range>
            <pub-id pub-id-type="pmid">19770534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yadav</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Parihar</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Todorov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kher</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chaurasia</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Pande</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Namdev</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Role of endoscopic third ventriculostomy in tuberculous meningitis with hydrocephalus.</article-title>
            <source>Asian J Neurosurg</source>
            <year>2016</year>
            <season>Oct-Dec</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>325</fpage>
            <page-range>325-329</page-range>
            <pub-id pub-id-type="pmid">27695532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suryaningtyas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ranuh</surname>
                <given-names>IGMAR</given-names>
              </name>
              <name>
                <surname>Parenrengi</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Shunt exposure as a ventriculoperitoneal shunt complication: A case series.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>79</volume>
            <fpage>484</fpage>
            <page-range>484-491</page-range>
            <pub-id pub-id-type="pmid">33757268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Surgery in hydrocephalus of tubercular origin: challenges and management.</article-title>
            <source>Acta Neurochir (Wien)</source>
            <year>2013</year>
            <month>May</month>
            <volume>155</volume>
            <issue>5</issue>
            <fpage>869</fpage>
            <page-range>869-73</page-range>
            <pub-id pub-id-type="pmid">23504056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizvi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Uniyal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Ventriculo-peritoneal shunt surgery for tuberculous meningitis: A systematic review.</article-title>
            <source>J Neurol Sci</source>
            <year>2017</year>
            <month>Apr</month>
            <day>15</day>
            <volume>375</volume>
            <fpage>255</fpage>
            <page-range>255-263</page-range>
            <pub-id pub-id-type="pmid">28320142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajshekhar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Three Decades of Vellore Grading for Tuberculous Meningitis with Hydrocephalus: A Reappraisal.</article-title>
            <source>Neurol India</source>
            <year>2021</year>
            <season>Nov-Dec</season>
            <volume>69</volume>
            <issue>Supplement</issue>
            <fpage>S569</fpage>
            <page-range>S569-S574</page-range>
            <pub-id pub-id-type="pmid">35103015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arshad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dayal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gadhe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mawley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tellez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Venketaraman</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Sep</month>
            <day>14</day>
            <volume>9</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">32937808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ssebambulidde</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gakuru</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cresswell</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Bahr</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet?</article-title>
            <source>Front Neurol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>892224</fpage>
            <pub-id pub-id-type="pmid">35711276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Laarhoven</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Dorp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Purnama</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Koeken</surname>
                <given-names>VACM</given-names>
              </name>
              <name>
                <surname>Diandini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Utami</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Livia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Apriani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ardiansyah</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ter Horst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Netea</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Achmad</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Ruslami</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alisjahbana</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ussher</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Indrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Verrall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ganiem</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>van Crevel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Jan</month>
            <day>29</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>884</fpage>
            <pub-id pub-id-type="pmid">30696839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Nhat</surname>
                <given-names>LTH</given-names>
              </name>
              <name>
                <surname>Thuong</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thanh</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>NTH</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Dalli</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.</article-title>
            <source>FASEB J</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>13028</fpage>
            <page-range>13028-13039</page-range>
            <pub-id pub-id-type="pmid">31500466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dixit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cerebrospinal Fluid Flow Analysis in Tuberculous Meningitis Using Phase Contrast Technique on 3 Tesla MRI: A New Paradigm and Our Initial Experience.</article-title>
            <source>Neurol India</source>
            <year>2022</year>
            <season>May-Jun</season>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>1025</fpage>
            <page-range>1025-1031</page-range>
            <pub-id pub-id-type="pmid">35864634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conradie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Diacon</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ngubane</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Everitt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crook</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mendel</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Egizi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moreira</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Timm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McHugh</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Bateson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Van Niekerk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olugbosi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spigelman</surname>
                <given-names>M</given-names>
              </name>
              <collab>Nix-TB Trial Team</collab>
            </person-group>
            <article-title>Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Mar</month>
            <day>05</day>
            <volume>382</volume>
            <issue>10</issue>
            <fpage>893</fpage>
            <page-range>893-902</page-range>
            <pub-id pub-id-type="pmid">32130813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saylor</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Neurologic Complications of Tuberculosis.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>992</fpage>
            <page-range>992-1017</page-range>
            <pub-id pub-id-type="pmid">34623101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mai</surname>
                <given-names>NTH</given-names>
              </name>
              <name>
                <surname>Dobbs</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Phu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Colas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Thao</surname>
                <given-names>LTP</given-names>
              </name>
              <name>
                <surname>Thuong</surname>
                <given-names>NTT</given-names>
              </name>
              <name>
                <surname>Nghia</surname>
                <given-names>HDT</given-names>
              </name>
              <name>
                <surname>Hanh</surname>
                <given-names>NHH</given-names>
              </name>
              <name>
                <surname>Hang</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Heemskerk</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thu</surname>
                <given-names>DDA</given-names>
              </name>
              <name>
                <surname>Merson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kestelyn</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wolbers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geskus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Summers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>NVV</given-names>
              </name>
              <name>
                <surname>Dalli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.</article-title>
            <source>Elife</source>
            <year>2018</year>
            <month>Feb</month>
            <day>27</day>
            <volume>7</volume>
            <pub-id pub-id-type="pmid">29482717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database.</article-title>
            <source>Infect Drug Resist</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>1281</fpage>
            <page-range>1281-1286</page-range>
            <pub-id pub-id-type="pmid">32440164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chakaya</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nantanda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mungai</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Migliori</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Amanullah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lungu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ntoumi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kumarasamy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Maeurer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zumla</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.</article-title>
            <source>Int J Infect Dis</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>124 Suppl 1</volume>
            <fpage>S26</fpage>
            <page-range>S26-S29</page-range>
            <pub-id pub-id-type="pmid">35321845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forget</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Adverse reactions to first-line antituberculosis drugs.</article-title>
            <source>Expert Opin Drug Saf</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-49</page-range>
            <pub-id pub-id-type="pmid">16503745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhiman</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Saraswat</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Rajekar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>YK</given-names>
              </name>
            </person-group>
            <article-title>A guide to the management of tuberculosis in patients with chronic liver disease.</article-title>
            <source>J Clin Exp Hepatol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-70</page-range>
            <pub-id pub-id-type="pmid">25755442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chitty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Ghani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kon</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Dzvova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Hateley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Routledge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.</article-title>
            <source>BMC Infect Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <day>24</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>231</fpage>
            <pub-id pub-id-type="pmid">28340562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous meningitis.</article-title>
            <source>JAMA</source>
            <year>1979</year>
            <month>Jan</month>
            <day>19</day>
            <volume>241</volume>
            <issue>3</issue>
            <fpage>264</fpage>
            <page-range>264-8</page-range>
            <pub-id pub-id-type="pmid">102806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rock</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Olin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Molitor</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system tuberculosis: pathogenesis and clinical aspects.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-61, table of contents</page-range>
            <pub-id pub-id-type="pmid">18400795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>JQ</given-names>
              </name>
            </person-group>
            <article-title>Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis.</article-title>
            <source>BMC Pulm Med</source>
            <year>2019</year>
            <month>Nov</month>
            <day>06</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>200</fpage>
            <pub-id pub-id-type="pmid">31694599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Iype</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balakrishnan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vijayakumar</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Predictors of mortality in patients with meningeal tuberculosis.</article-title>
            <source>Neurol India</source>
            <year>2012</year>
            <season>Jan-Feb</season>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-22</page-range>
            <pub-id pub-id-type="pmid">22406774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome.</article-title>
            <source>Front Neurol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>830029</fpage>
            <pub-id pub-id-type="pmid">35370906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kasibante</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Namudde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bangdiwala</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Kabahubya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakasujja</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lofgren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boulware</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Meya</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Cresswell</surname>
                <given-names>FV</given-names>
              </name>
            </person-group>
            <article-title>Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort.</article-title>
            <source>Wellcome Open Res</source>
            <year>2021</year>
            <volume>6</volume>
            <fpage>208</fpage>
            <pub-id pub-id-type="pmid">35949653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasouli</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Mirkoohi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vaccaro</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Yarandi</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Rahimi-Movaghar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Spinal tuberculosis: diagnosis and management.</article-title>
            <source>Asian Spine J</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>294</fpage>
            <page-range>294-308</page-range>
            <pub-id pub-id-type="pmid">23275816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Somvanshi</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Spinal tuberculosis: a review.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2011</year>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>440</fpage>
            <page-range>440-54</page-range>
            <pub-id pub-id-type="pmid">22118251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koplay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erdogan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sivri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nayman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paksoy</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Unusual reason of spinal cord infarction: tuberculous meningitis.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-9</page-range>
            <pub-id pub-id-type="pmid">26143304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cocozza</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Linh</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Nathavitharana</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Jaramillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gargioni</surname>
                <given-names>GEM</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>An assessment of current tuberculosis patient care and support policies in high-burden countries.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2020</year>
            <month>Jan</month>
            <day>01</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-42</page-range>
            <pub-id pub-id-type="pmid">32005305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daftary</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>EMH</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>MJA</given-names>
              </name>
              <name>
                <surname>Fekadu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goosby</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>1114</fpage>
            <page-range>1114-1116</page-range>
            <pub-id pub-id-type="pmid">30226149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of pharmaceutical care on treatment outcomes for patients with first-time pulmonary tuberculosis in China.</article-title>
            <source>J Clin Pharm Ther</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>888</fpage>
            <page-range>888-894</page-range>
            <pub-id pub-id-type="pmid">30003561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muthu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dhooria</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Behera</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>Outcome of Critically Ill Subjects With Tuberculosis: Systematic Review and Meta-Analysis.</article-title>
            <source>Respir Care</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>12</issue>
            <fpage>1541</fpage>
            <page-range>1541-1554</page-range>
            <pub-id pub-id-type="pmid">30206126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135305.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>LoBue</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewinsohn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Loeffler</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mazurek</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richeldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shinnick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Warshauer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Jan</month>
            <day>15</day>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-115</page-range>
            <pub-id pub-id-type="pmid">28052967</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
